Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-20

Clinical Trial Update: Minocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in Schizophrenia [Phase 3]

View source ↗

Summary

This entry reports a Phase 3 clinical trial evaluating minocycline as an add-on to antipsychotics for negative and cognitive symptoms in schizophrenia. The curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: Beer Yaakov - Ness Ziona Mental Health Center | Conditions: Schizophrenia | Phase 3 | Status: UNKNOWN